TY-0540

N/A

Report date: 2025/04/28 22:35:30
NME

Base Information

Drug NameTY-0540
Drug Alias NameTY-0540TY0540TY-00540TYK-00540
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsSolid tumoursHR-positive breast cancerNeoplasm Metastasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTYK Medicines Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTYK Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHR-positive breast cancerNeoplasm Metastasis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A